Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection
- PMID: 30416941
- PMCID: PMC6215991
- DOI: 10.7150/jbji.27718
Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection
Abstract
We reviewed all outpatients with bone and joint infection treated with cefoxitin in continuous intravenous infusion using mobile elastomeric infusors in our regional reference center between 2014 and 2017. The stability of cefoxitin provides an interesting and well-tolerated alternative for continuous infusion in outpatients with polymicrobial bone and joint infection.
Keywords: bone; cefoxitin; infusor; joint.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
References
-
- American Society of Health-System Pharmacists. Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery. 2013. Available from: https:// www.ashp.org/-/media/assets/policy-guidelines/docs/therapeutic-guideline.... - PubMed
-
- Schurman DJ, Dillingham M. Clinical evaluation of cefoxitin in treatment of infections in 47 orthopedic patients. Rev Infect Dis. 1979 Feb;1(1):206–9. - PubMed
-
- Webb D, Thadepalli H, Bach V, Roy I. Clinical and experimental evaluation of cefoxitin therapy. Chemotherapy. 1979;25(4):233–42. - PubMed
-
- Perkins RL, Slama TG, Fass RJ, Prior RB, Plouffe JF, Warner JF. et al. Therapy of skin, soft tissue, and bone infections with cefoxitin sodium. Rev Infect Dis. 1979 Feb;1(1):165–9. - PubMed
-
- Cefoxitin - FDA prescribing information, side effects and uses. Drugs.com. Available from: https:// www.drugs.com/pro/cefoxitin.html.
LinkOut - more resources
Full Text Sources